19 May 2023 - Patent-protected medicines cost an average 5.4% less in other European countries than in Switzerland, and 10.8% less for off-patent medicines.
This is according to the latest annual study by Santésuisse and Interpharma, umbrella organisations for Swiss insurers and pharmaceutical research companies.